Cryoport, Inc.

Fundamentals5.0
Price Action7.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong liquidity
  • Weak cash flow
  • Operating losses

AI
AI Summary

6.0

CYRX's investment case has shifted from proving demand to proving operating leverage: revenue growth, raised guidance, and expanding CGT/trial volume are real, but negative cash flow and still-elevated opex mean the stock likely needs sustained execution—not just another beat—to justify its recent breakout.

GrowthOpportunity
CashFlowRisk
Execution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • Strong liquidity
  • Weak cash flow
  • Operating losses

Cryoport shows strong liquidity and manageable leverage, but weak cash conversion and a recent quarterly loss mean earnings quality and operating efficiency remain the main risks despite a modest valuation.

liquidity
cashflow

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Breakout Momentum
  • Range Highs
  • Pullback Risk

CYRX has shown a strong breakout and uptrend over the last month, but after peaking at $13.60 it is now consolidating near range highs, so holding $12.70–$12.80 is key to keep the bullish setup intact.

breakout
consolidation
Support Level: $12.70–$12.80
Resistance Level: $13.60

Sharp breakout above $10.60 followed by a rapid run to $13.60, then a mild pullback

Sentiment & News

6.0

Key News Insights:

  • Revenue Acceleration
  • CGT Strength
  • Wider Loss

Cryoport posted solid Q1 2026 revenue growth driven by strong CGT demand and raised full-year guidance, though wider-than-expected losses still weigh on profitability.

Growth
Guidance

The results are modestly positive for Cryoport's outlook, as accelerating core growth and higher guidance outweigh ongoing earnings pressure